General form of registration statement for all companies including face-amount certificate companies

Note 8 - Stockholders' Equity (Tables)

v2.4.1.9
Note 8 - Stockholders' Equity (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Note 8 - Stockholders' Equity (Tables) [Line Items]    
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]

Fair value at December 31, 2013

  $ 3,747,858  

Gain on change in fair value of derivative liabilities

    (578,179 )

Fair value at September 30, 2014

  $ 3,169,679  

Balance at January 1, 2012

  $ -  

Fair value of July 2012 warrants at transaction date

    1,957,720  

Loss on change in fair value

    170,582  

Balance at December 31, 2012

    2,128,302  

Fair value of January 2013 warrants at transaction date

    3,305,245  

Gain on change in fair value of derivative liabilities

    (1,685,689 )

Balance at December 31, 2013

  $ 3,747,858  
Impact of Conversions to Common Stock [Table Text Block]  
   

Impact to Balance Sheet

   

Increase in

 
   

Before

Conversions

   

Impact of

Conversions

   

After

Conversions

   

Common Shares

Outstanding

 
                                 

Impact on assets

                               

Deferred costs

  $ 799,123     $ (799,123 )   $ -       -  
                                 

Impact on liabilities and equity

                               

Accrued interest on converted notes

  $ 974,311     $ (974,311 )   $ -       1,092,559  

Summer 2011 Notes, net

    904,397       (904,397 )     -       2,183,334  

March 2010 Notes, net

    4,057,500       (4,057,500 )     -       4,071,000  

2011 Unit Offering Notes, net

    4,367,482       (4,367,482 )     -       9,050,834  

Total impact on liabilities

    10,303,690       (10,303,690 )     -       16,397,727  

Series A convertible preferred stock

    7,965,000       (7,965,000 )     -       7,965,000  

Additional paid-in capital and common stock

    -       19,345,209       19,345,209       -  

Accumulated deficit

    -       (1,875,642 )     (1,875,642 )     -  

Total impact on equity

    7,965,000       9,504,567       17,469,567       7,965,000  

Total impact on liabilities and equity

  $ 18,268,690     $ (799,123 )   $ 17,469,567       24,362,727  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
   

Shares

   

Weighted -

Average

Exercise

Price

 

Outstanding at December 31, 2013

    7,430,225     $ 1.47  

Granted

    417,000       1.05  

Exercised

    (162,500 )     0.88  

Forfeited

    (130,000 )     1.88  

Outstanding at September 30, 2014

    7,554,725       1.46  
   

Options

Outstanding

   

Options

Exercisable

   

Range of

Exercise Prices

   

Weighted-

average

Exercise

price per

share

   

Intrinsic

Value(1)

 

Balance at January 1, 2012

    3,679,977             $ 0.88   -   $ 9.64     $ 2.05     $ -  

Exercisable at January 1, 2012

            1,501,659       0.88   -     9.64       2.15       -  

Granted (2)

    3,097,400               1.00         2.13       1.08          

Exercised

    (14,000 )             1.80   -     9.64       1.80          

Cancelled or forfeited

    (331,250 )             1.80   -     9.64       2.14          

Outstanding at December 31, 2012

    6,432,127               0.88   -     9.64       1.58       1,846,040  

Exercisable at December 31, 2012

            2,386,909       0.88   -     9.64       2.13       205,000  

Granted (2)

    1,219,500               1.09   -     1.75       1.43          

Cancelled or forfeited

    (221,402 )             1.00   -     9.64       4.33          

Outstanding at December 31, 2013

    7,430,225               0.88   -     9.64       1.47       1,493,368  

Exercisable at December 31, 2013

            4,416,292       0.88   -     9.64       1.68       566,589  
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]  
     

Options Outstanding

   

Options Exercisable

 

Range of 

Exercise Prices

   

Number

Outstanding

   

Weighted -

Average

Remaining

Contractual

Life

   

Weighted -

Average

Exercise

Price

   

Number

Exercisable

   

Weighted -

Average

Remaining

Contractual

Life

   

Weighted -

Average

Exercise

Price

 
$0.88 - $1.26       3,375,650       7.31     $ 1.01    

1,189,384

      6.36     $ 0.97  
1.40 - 2.13       3,948,450       8.29       1.74    

3,120,783

      7.40       1.79  
3.20 - 9.64       106,125       4.17       6.16       106,125       4.17       6.16  
            7,430,225       7.79       1.47    

4,416,292

      7.04       1.68  
Schedule of Nonvested Share Activity [Table Text Block]  

Nonvested Stock Options

 

Shares

   

Weighted -

Average

Grant Date

Fair Value

 

Nonvested January 1, 2012

    2,178,318       0.87  

Granted

    3,097,400       0.48  

Forfeited

    (258,516 )     0.85  

Vested

    (971,984 )     1.04  

Nonvested December 31, 2012

    4,045,218       0.56  

Granted

    1,219,500       0.63  

Forfeited

    (94,833 )     0.76  

Vested

    (2,155,952 )     0.58  

Nonvested December 31, 2013

    3,013,933       0.52  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Dividend yield

    0%  

Expected volatility

    49.7% to 51.8%  

Risk free interest rates

    1.90% to 2.71%  

Expected lives (in years)

    5.5 to 6.0  
   

Years Ended December 31,

 
   

2013

   

2012

 

Dividend yield

    0%         0%    

Expected Volatility

  43.4% to 46.0%     45.2% to 45.3%  

Risk free Interest rates

  0.92% to 2.10%     0.83% to 1.13%  
Expected lives (years)   5.0 - 6.0       6.0    
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
   

Shares

   

Weighted -

Average

Exercise

Price

 

Outstanding at December 31, 2013

    12,136,865     $ 1.33  

Issued (see Note 5)

    1,190,250       1.75  

Outstanding at September 30, 2014

    13,327,115       1.37  
   

Shares

   

Weighted -

Average

Exercise

Price

 

Outstanding at January 1, 2012

    1,922,944     $ 0.43  

Issued

    7,652,071       1.05  

Shares withheld on net settled exercises

    (186,347 )     0.70  

Exercised

    (624,832 )     0.67  

Outstanding at December 31, 2012

    8,763,836       0.95  

Expired

    (41,666 )     1.00  

Issued

    4,643,842       1.75  

Shares withheld on net settled exercises

    (101,318 )     0.85  

Exercised

    (1,127,829 )     0.08  

Outstanding at December 31, 2013

    12,136,865       1.33  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

Three Months Ended September 30,

   

Nine Months Ended September 30,

 

2014

   

2013

   

2014

   

2013

 
$ 192,001     $ 345,632     $ 555,909     $ 988,223  
 
Common Stock Warrants Issued in Private Placement [Member]    
Note 8 - Stockholders' Equity (Tables) [Line Items]    
Assumptions Used in Calculating Fair Value of Warrants Issued [Table Text Block]

Dividend yield

    0%  

Expected volatility

    38.5% - 100.0%  

Risk free interest rates

    0.76% - 1.18%  

Expected remaining term (in years)

    2.76 to 3.32  
 
Private Placements [Member]    
Note 8 - Stockholders' Equity (Tables) [Line Items]    
Assumptions Used in Calculating Fair Value of Warrants Issued [Table Text Block]  
                       

Transaction Date

 
   

December 31,

   

January 2013

   

July 2012

 
   

2013

   

2012

   

Financing

   

Financing

 

Dividend yield

    0%         0%         0%         0%    

Expected volatility

  40.38% - 100.00%       47.08%       47.08% - 100.00%       47.64%    

Risk free interest rates

  1.01% - 1.27%       0.65%         0.91%         0.75%    

Expected remaining term (in years)

  3.51 to 4.07       4.51          5.00         5.00     
Director [Member]    
Note 8 - Stockholders' Equity (Tables) [Line Items]    
Assumptions Used in Calculating Fair Value of Warrants Issued [Table Text Block]  
  Year Ended December 31,  
  2013   

2012

 

Dividend yield

  0%       0%    

Expected Volatility

  46.49%     40.96% to 46.88%  

Risk free Interest rates

  1.38%     0.19% to 0.77%  
Expected lives (years)   5.0     1.6  to 5.0